Response to Comments: Non-Invasive Vascular Studies

The LCD was updated to add evidence supporting expanded coverage for arterial fibromuscular dysplasia (FMD) for non-invasive vascular studies. No other changes were made to the LCD; no public comments were received on the changed section and two questions about the existing LCD were addressed in the accompanying article.

"Coverage was expanded to include non-invasive vascular studies for arterial fibromuscular dysplasia based on added supporting evidence."

Sign up to see full coverage criteria, indications, and limitations.